Key facts
- LeapScribe’s last known valuation is $260K (Mar 2025).
- It has raised $30K; the latest was Buyout/LBO in May 2025.
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for LeapScribe
- ·The full record, as it builds
Funding rounds
No funding rounds for LeapScribe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LeapScribe
Developer of artificial intelligence-driven medical documentation solutions designed to streamline administrative tasks in healthcare settings. The company's platform enables healthcare professionals to record patient consultations, automatically generating structured documentation, including referrals and medical certificates, through features such as conversation recording, intelligent dictation without manual punctuation, and integration of free-text inputs from various sources, enabling medical professionals to enhance patient care by reducing administrative burdens.
- Sector
- Healthcare
- HQ
- Umea, Sweden
- Founded
- 2023
- Employees
- 10
- Website
- leapscribe.se/
- Ownership
- Acquired/Merged (Operating Subsidiary)
LeapScribe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LeapScribe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LeapScribe in its N-PORT filings yet. We sweep new filings monthly.